Sol-Gel Technologies (SLGL) Assets Average (2017 - 2026)

Sol-Gel Technologies (SLGL) reported Assets Average of $44.2 million for Q1 2026, up 40.63% year-over-year from $31.5 million in Q1 2025, and up 37.14% quarter-over-quarter from $32.3 million in Q4 2025.

Sol-Gel Technologies (SLGL) Assets Average (2017 - 2026) Analysis & Trends

Sol-Gel Technologies (SLGL) has 10 years of Assets Average data on file, last reported at $44.2 million in Q1 2026.

  • Assets Average for Q1 2026 came in at $44.2 million, up 40.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $44.2 million (up 40.63% YoY), and the FY2025 annual result was $32.9 million, down 18.94% from the prior year.
  • Assets Average advanced to $44.2 million in Q1 2026 per SLGL's latest filing, from $32.3 million in the prior quarter.
  • Over five years, Assets Average peaked at $62.6 million in Q1 2022 and troughed at $31.5 million in Q1 2025.
  • A 5-year average of $44.9 million and a median of $44.2 million in 2026 frame the typical range for Assets Average.
  • The sharpest annual moves came in 2025 and 2026: Assets Average dropped 26.16% in 2025, then surged 40.63% in 2026.
  • A 5-year view of Assets Average shows it stood at $49.0 million in 2022, then fell by 2.83% to $47.6 million in 2023, then decreased by 17.16% to $39.4 million in 2024, then declined by 18.16% to $32.3 million in 2025, then soared by 37.14% to $44.2 million in 2026.
  • Business Quant data shows SLGL's Assets Average at $44.2 million in Q1 2026, $32.3 million in Q4 2025, and $36.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 33.42 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 795.91 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 13.04 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.72 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 26.03 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 40.89 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 10.06 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 26.06 Bn
9 Abivax 91.96 Bn 91.96 Bn - 660.38 Mn
10 Sol-Gel Technologies 207.80 Mn 197.67 Mn - 44.23 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 44.23 Mn
Dec 31, 2025 32.25 Mn
Sep 30, 2025 36.95 Mn
Jun 30, 2025 33.19 Mn
Mar 31, 2025 31.45 Mn
Dec 31, 2024 39.41 Mn
Sep 30, 2024 42.49 Mn
Jun 30, 2024 40.96 Mn
Mar 31, 2024 42.60 Mn
Dec 31, 2023 47.57 Mn
Sep 30, 2023 52.48 Mn
Jun 30, 2023 52.07 Mn
Mar 31, 2023 47.84 Mn
Dec 31, 2022 48.96 Mn
Sep 30, 2022 53.14 Mn
Jun 30, 2022 55.52 Mn
Mar 31, 2022 62.62 Mn
Dec 31, 2021 61.01 Mn
Sep 30, 2021 49.62 Mn
Jun 30, 2021 50.01 Mn